|
Title
|
|
|
|
Marketing of unproven stem cell-based interventions: a call to action
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Science translational medicine. - -
|
|
|
Publication
|
|
|
|
2017
|
|
|
ISSN
|
|
|
|
1946-6234
|
|
|
DOI
|
|
|
|
10.1126/SCITRANSLMED.AAG0426
|
|
|
Volume/pages
|
|
|
|
9
:397
(2017)
, p. 1-5
|
|
|
ISI
|
|
|
|
000404734300002
|
|
|
Note
|
|
|
|
Article Number: eaag0426
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|